Survivors of childhood, adolescent, and young adult (diagnosed when< 25 years of age)
cancer are at risk of mental health problems. The aim of this clinical practice guideline is to …

Background Treatment strategies for childhood cancer are improving, resulting in higher
survival rates. However, the consequences of childhood cancer do not end with the …

Background Increasing attention has been dedicated to investigate modifiable risk factors of
late effects in survivors of childhood cancer. This study aims to evaluate neurocognitive and …

Advancements in cancer treatments over the past several decades have led to improved
cancer survival in adolescents and young adults (AYAs, ages 15–39 years). However, AYA …

The majority of childhood cancer patients survive well into adulthood, but remain at risk for
psychological late effects that can impact overall health and quality of life. The current …

Aims and objectives To systematically review the existing literature reporting symptoms in
childhood and adolescent and young adult cancer survivors and to meta‐analyse the …

Objective Improved treatment landscape has led to better outcomes for paediatric acute
lymphoblastic leukemia (ALL) survivors. As the number of survivors increase, we need to …

Late effects such as neurocognitive issues and fatigue have been reported in childhood
acute lymphoblastic leukemia (cALL) survivors. Yet, their association is often poorly …

Background The improvement in treatment of pediatric acute lymphatic leukemia (ALL) has
introduced new challenges for pediatric oncology care in understanding and handling long …

Abstract The National Cancer Institute (NCI) has a 40‐year history of initiatives to encourage
the participation of community oncology sites into clinical trials research and clinical care. In …